menu Search
Ambitech
Qualimed

JOINT STOCK COMPANY BIOCAD

Featured products of BIOCAD
Acellbia
Acellbia conc for soln for infusion 100 mg/10 mL
rituximab
Packing/Price
2 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Acellbia conc for soln for infusion 500 mg/50 mL
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Bevalast
Bevalast conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Bevalast conc for soln for infusion 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Bonmab
Bonmab conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Bonmab conc for soln for infusion 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Herticad
Herticad powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Herticad powd for conc for soln for infusion 440 mg
trastuzumab
Packing/Price
(vial + 20 mL vial solvent) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Rituxell
Rituxell conc for soln for infusion 100 mg/10 mL
rituximab
Packing/Price
1 × 2's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Rituxell conc for soln for infusion 500 mg/50 mL
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Distributed by Ambitech
Acellbia
Acellbia conc for soln for infusion 100 mg/10 mL
rituximab
Packing/Price
2 × 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Acellbia conc for soln for infusion 500 mg/50 mL
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Bonmab
Bonmab conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Bonmab conc for soln for infusion 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Herticad
Herticad powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
(vial) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Herticad powd for conc for soln for infusion 440 mg
trastuzumab
Packing/Price
(vial + 20 mL vial solvent) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Distributed by Qualimed
Bevalast
Bevalast conc for soln for infusion 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Bevalast conc for soln for infusion 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Rituxell
Rituxell conc for soln for infusion 100 mg/10 mL
rituximab
Packing/Price
1 × 2's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Rituxell conc for soln for infusion 500 mg/50 mL
rituximab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.